To address whether the tumor suppressive phenotype of Egln3 was intrinsically linked to hydroxylase activity, we generated an enzymatically defective Egln3 mutant through the alteration of a catalytically critical histidine residue (i.e. H196A) [26], [34], [43]. Here, EGLN3 is linked to neoplasm.